<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02725528</url>
  </required_header>
  <id_info>
    <org_study_id>PSI 2016-03</org_study_id>
    <nct_id>NCT02725528</nct_id>
  </id_info>
  <brief_title>Evaluation of Xiaflex: Trial of Effectivenss iN Dupuytren's</brief_title>
  <acronym>EXTEND</acronym>
  <official_title>A Multi-Center, Randomized Controlled Trial Comparing The Clinical Effectiveness and Cost-Effectiveness of Collagenase Injection (Xiaflex) and Palmar Fasciectomy in the Management of Dupuytren's Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>McMaster University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>The Physicians' Services Incorporated Foundation</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>McMaster University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a prospective, multi-centre, pragmatic randomized controlled trial to compare both
      the clinical effectiveness and cost-effectiveness of collagenase injections (CI) versus
      limited palmar fasciectomy (LPF) to determine if collagenase is a superior treatment in terms
      of improved quality of life and reducing recurrence of the disease without serious
      complications. Since collagenase injections are costly it is also important to know if this
      novel intervention is cost-effective from the patient, Ministry of Health and societal
      perspectives.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">July 8, 2017</start_date>
  <completion_date type="Anticipated">November 2018</completion_date>
  <primary_completion_date type="Anticipated">July 2018</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>health-related quality of life (HRQL) using the Michigan Hand Outcomes Questionnaire (MHQ)</measure>
    <time_frame>1 year</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>HRQL measured with the Health Utility Index Mark 3 (HUI3) of Health)</measure>
    <time_frame>1 year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>HRQL measured with the Unité Rhumatologique des Affections de la Main (URAM)</measure>
    <time_frame>1 year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>HRQL measured with the Southampton Dupuytren's Scoring Scheme (SDSS)</measure>
    <time_frame>1 year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality Adjusted Life Years (QALY) measured with the Health Utility Index Mark 3 (HUI3)</measure>
    <time_frame>1 year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Self-reported healthcare utilization</measure>
    <time_frame>1 year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Range of motion (ROM) of hand joints</measure>
    <time_frame>1 year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Recurrence rates</measure>
    <time_frame>1 year</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">128</enrollment>
  <condition>Dupuytren's Disease</condition>
  <arm_group>
    <arm_group_label>collagenase injection</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>This procedure will be performed either in a minor procedure room or the hand clinic as per surgeon's routine practice. Collagenase will be administered with or without local anesthesia. As this is a pragmatic study there may be more than one digit injected at a time just as surgery occurs on more than one digit at a time. A recently published study by Gaston et al confirmed that two concurrent injections of collagenase to 2 affected joints in the same hand are generally well tolerated and the frequency of most adverse events (AEs) is similar to those reported in studies that use single sequential injections.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>limited palmar fasciectomy</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The Dupuytren's cord will be excised under local anesthesia in a minor procedure room setting or main operating room under local or general anesthetic depending on the complexity of the disease and the surgeon's routine. As this is a pragmatic study comparison of collagenase injections (novel intervention) to limited palmar fasciectomy as it is actually presently performed in all settings academic or community (local in minor room or general/local anesthetic in the main operating room) will be examined. Surgery will be performed according to the operating surgeon's preferred technique i.e. zig-zag Brunner incision or straight incision with z-plasty closure of the skin.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>collagenase injection</intervention_name>
    <description>injection</description>
    <arm_group_label>collagenase injection</arm_group_label>
    <other_name>enzyme, collagenase clostridium histolyticum, xiaflex</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>limited palmar fasciectomy</intervention_name>
    <description>surgery</description>
    <arm_group_label>limited palmar fasciectomy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. 18 years of age or older

          2. Dupuytren's contracture of the metacarpophalangeal (MCP) joint or of the proximal
             interphalangeal (PIP) joint with a fixed flexion contracture of 20º or greater in at
             least 1 finger (not the thumb)

          3. Demonstrated inability to simultaneously place the affected finger and palm flat on a
             table

          4. Able to understand and communicate in English

        Exclusion Criteria:

          1. Previous treatment of the primary joint within 90 days of study inclusion

          2. Patients undergoing any concomitant procedure on the same hand (e.g. carpal tunnel
             release, stenosing tenosynovitis release)

          3. Persistent extension deficit from a previous surgery of the same digit

          4. Any chronic muscular or neuromuscular disorder affecting wrist or hand

          5. Patient generally unfit for surgery

          6. Patient with specific treatment preference

          7. Bleeding disorder or recent stroke

          8. Allergy to collagenase

          9. Collagenase treatment or treatment with any investigational drug within 30 days of
             study inclusion

         10. Use of a tetracycline derivative within 14 days of first dose of study drug (because
             tetracycline derivatives may inhibit the collagenolytic activity of mammalian
             collagenase homologs [i.e., matrix metalloproteinases])

         11. Pregnant or breast feeding patients

         12. Patients who do not have insurance coverage for collagenase injections

         13. Patients who are unable to provide informed consent or are unable to complete quality
             of life questionnaires due to mental capacity or neuro-psychological problems.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Achilleas Thoma, MD MSc FRCSC</last_name>
    <role>Principal Investigator</role>
    <affiliation>McMaster University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Achilleas Thoma, MD MSc FRCSC</last_name>
    <phone>905-523-0019</phone>
    <email>athoma@mcmaster.ca</email>
  </overall_contact>
  <location>
    <facility>
      <name>Hamilton Health Sciences</name>
      <address>
        <city>Hamilton</city>
        <state>Ontario</state>
        <zip>L8N 3Z5</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>James Bain, MD</last_name>
      <phone>905-521-2100</phone>
      <phone_ext>73222</phone_ext>
    </contact>
  </location>
  <location>
    <facility>
      <name>St. Joseph's Healthcare / McMaster University</name>
      <address>
        <city>Hamilton</city>
        <state>Ontario</state>
        <zip>L8N 4A6</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Achilleas Thoma, MD MSc FRCSC</last_name>
      <phone>905-523-0019</phone>
      <email>athoma@mcmaster.ca</email>
    </contact>
    <investigator>
      <last_name>Achilleas Thoma, MD MSc FRCSC</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>St. Joseph's Hospital</name>
      <address>
        <city>Hamilton</city>
        <state>Ontario</state>
        <country>Canada</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Carolyn Levis, MD</last_name>
      <phone>905-308-9419</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>St. Joseph's Healthcare</name>
      <address>
        <city>London</city>
        <state>Ontario</state>
        <zip>N6A 4V2</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Bing Gan, MD</last_name>
      <phone>519-646-6097</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Markham Stouffville Hospital</name>
      <address>
        <city>Markham</city>
        <state>Ontario</state>
        <zip>L6B 0T1</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Tara Lynn Teshima, MD</last_name>
      <phone>289-597-6775</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>679 Davis St. Suite 209</name>
      <address>
        <city>Newmarket</city>
        <state>Ontario</state>
        <zip>L3Y 5G8</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Bimpe Ayeni, MD</last_name>
      <phone>905-853-6644</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Halton Healthcare Services</name>
      <address>
        <city>Oakville</city>
        <state>Ontario</state>
        <zip>L6J 0B2</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Nancy de Kleer, MD</last_name>
      <phone>905-901-9545</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Oakville Trafalgar Hospital</name>
      <address>
        <city>Oakville</city>
        <state>Ontario</state>
        <country>Canada</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Rodger Shortt, MD</last_name>
      <phone>905-849-4282</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>The Ottawa Hospital</name>
      <address>
        <city>Ottawa</city>
        <state>Ontario</state>
        <zip>K1Y 4E9</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Murray Allen</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>North York General Hospital</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <zip>M2J 1V1</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Yasser El-Sheikh, MD</last_name>
      <phone>416-782-7788</phone>
    </contact>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>January 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 22, 2016</study_first_submitted>
  <study_first_submitted_qc>March 29, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 1, 2016</study_first_posted>
  <last_update_submitted>January 2, 2018</last_update_submitted>
  <last_update_submitted_qc>January 2, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">January 4, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>McMaster University</investigator_affiliation>
    <investigator_full_name>Achilleas Thoma</investigator_full_name>
    <investigator_title>Dr. Achllieas Thoma</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dupuytren Contracture</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

